(VIANEWS) - Sunstone Hotel Investors Sunstone Hotel Investors (SHO), Esquire Financial Holdings (ESQ), Credicorp Ltd. (BAP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Sunstone Hotel Investors Sunstone Hotel Investors (SHO)
43.9% sales growth and 4.88% return on equity
Sunstone Hotel Investors, Inc., a lodging real-estate investment trust ("REIT"), has interest in 19 hotels with 9,997 rooms. Sunstone is a company that acquires, manages, assets, renovates, or repositions hotels that are considered long-term relevant real estateA(r). Most of these hotels are owned by nationally recognized brands like Marriott, Hilton, and Hyatt.
Sunstone Hotel Investors Sunstone Hotel Investors's sales growth this year is anticipated to be 63% and 11.5% for next year.
Year-on-year quarterly revenue growth grew by 238.3%, now sitting on 629.83M for the twelve trailing months.
Volume
Today's last reported volume for Sunstone Hotel Investors Sunstone Hotel Investors is 2280210 which is 48.07% below its average volume of 4391690.
Sunstone Hotel Investors Sunstone Hotel Investors's sales growth for the next quarter is 43.9%. The company's growth estimates for the present quarter and the next is 137.5% and 153.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.88%.
Volatility
Sunstone Hotel Investors Sunstone Hotel Investors's last day, last week, and last month's current intraday variation average was 2.59%, 2.56%, and 1.84%, respectively.
Sunstone Hotel Investors Sunstone Hotel Investors's highest amplitude of average volatility was 3.16% (day), 3.38% (last week), and 3.03% (last month), respectively.
Sunstone Hotel Investors Sunstone Hotel Investors's Stock Yearly Top and Bottom Value
Sunstone Hotel Investors Sunstone Hotel Investors's stock is valued at $11.19 at 11:22 EST, way under its 52-week high of $13.91 and way higher than its 52-week low of $9.30.
Sunstone Hotel Investors Sunstone Hotel Investors's Moving Average
Sunstone Hotel Investors Sunstone Hotel Investors's worth is above its 50-day moving average of $10.96 and below its 200-day moving average of $11.27.2. Esquire Financial Holdings (ESQ)
33.3% sales growth and 14.95% return on equity
Esquire Financial Holdings, Inc. is the bank holding firm for Esquire Bank, National Association. It provides services and products in commercial banking to small and large businesses, legal industries, as well as commercial customers. It offers time, checking and savings deposits as well as certificates. The company also offers short-term financing, which includes inventory, receivables or the purchase of supplies. It also has commercial credit, lines of credit, consumer loans (post-settlement consumer or structured settlement loans for plaintiffs or claimants), as well loans to consumers for debt consolidation, life expenses, payments of outstanding bills or any other needs. Real estate loans include multifamily, residential and commercial real estate as well merchant services. The company had a Jericho branch that provided full service and an administrative office located in Boca Raton. Esquire Financial Holdings, Inc., was established in 2006. It is located in Jericho, New York.
Esquire Financial Holdings's sales growth this year is expected to be 27.9% and 21.1% for next year.
Year-on-year quarterly revenue growth grew by 24.5%, now sitting on 64.45M for the twelve trailing months.
Volume
Today's last reported volume for Esquire Financial Holdings is 11429 which is 78.76% below its average volume of 53809.
Esquire Financial Holdings's sales growth is a negative 0% for the ongoing quarter and 33.3% for the next. The company's growth estimates for the current quarter and the next is 171.9% and 9.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.95%.
Volatility
Esquire Financial Holdings's last day, last week, and last month's current intraday variation average was 0.85%, 0.92%, and 1.10%, respectively.
Esquire Financial Holdings's highest amplitude of average volatility was 2.86% (day), 3.12% (last week), and 2.76% (last month), respectively.
Esquire Financial Holdings's Stock Yearly Top and Bottom Value
Esquire Financial Holdings's stock is valued at $36.59 at 11:23 EST, way under its 52-week high of $41.68 and way higher than its 52-week low of $26.06.
Esquire Financial Holdings's Moving Average
Esquire Financial Holdings's worth is above its 50-day moving average of $36.48 and above its 200-day moving average of $34.58.3. Credicorp Ltd. (BAP)
17.5% sales growth and 17.14% return on equity
Credicorp Ltd. is a holding company for financial services. It provides a variety of financial and insurance products, as well as financial and other services, both in Peru and abroad. Universal Banking, the company's segment, offers current and deposits as well as various financial instruments and credits to legal entities and individuals. The Insurance and Pensions segment provides insurance policies for commercial property, transport, vessels, vehicles, life and health. It also manages private pension funds and offers management services. Microfinance, a subsidiary of the company, manages microenterprises' current and future accounts, loans, credit, deposits and current accounts. The company's Investment Banking and Wealth Management section offers services to institutions, foundations, corporations and governments. It structures and places issues on the primary and secondary markets, and executes and negotiates operations in the second market. Additionally, it manages mutual funds and securitizations for corporate clients. It was established in Lima in Peru in 1889.
Credicorp Ltd.'s sales growth this year is expected to be 19.9% and 10.9% for next year.
Year-on-year quarterly revenue growth grew by 24%, now sitting on 14.76B for the twelve trailing months.
Volume
Today's last reported volume for Credicorp Ltd. is 147828 which is 50.86% below its average volume of 300864.
Credicorp Ltd.'s sales growth for the next quarter is 17.5%. The company's growth estimates for the present quarter and the next is 1.4% and 11.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.14%.
Volatility
Credicorp Ltd.'s last day, last week, and last month's current intraday variation average was 1.14%, 0.82%, and 1.19%, respectively.
Credicorp Ltd.'s highest amplitude of average volatility was 1.49% (day), 2.15% (last week), and 2.27% (last month), respectively.
Credicorp Ltd.'s Stock Yearly Top and Bottom Value
Credicorp Ltd.'s stock is valued at $130.85 at 11:24 EST, way below its 52-week high of $182.11 and way above its 52-week low of $103.01.
Credicorp Ltd.'s Moving Average
Credicorp Ltd.'s value is above its 50-day moving average of $128.52 and below its 200-day moving average of $136.73.4. Advanced Energy Industries (AEIS)
14.3% sales growth and 15.81% return on equity
Advanced Energy Industries, Inc. manufactures, markets, supports, and sells precision power conversion, measurement, control, and control solutions around the world. The company offers plasma power solutions including pulsed DC (DC), direct current (DC), low frequency alternating current (HF), and high voltage (RF) power sources. It also provides RF power supplies and matching networks as well as products and services for RF instrumentation. Remote plasma sources are available for reactive gas applications. It also offers power control modules, thermal instrumentation products, for chemical vapor processing, epitaxy and crystal growing. It also offers products that monitor the gas market, automobile emissions monitoring and testing, as well embedded power products. It also offers repair and conversion services, including upgrades and refurbishments of used equipment and new equipment. It sells its products via a direct sales team, independent sales reps, channel partners and distributors. Advanced Energy Industries, Inc., was established in 1981. It is located in Denver, Colorado.
Advanced Energy Industries's sales growth this year is expected to be 18.6% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 22%, now sitting on 1.58B for the twelve trailing months.
Volume
Today's last reported volume for Advanced Energy Industries is 157457 which is 9.12% below its average volume of 173261.
Advanced Energy Industries's sales growth is a negative 0% for the present quarter and 14.3% for the next. The company's growth estimates for the current quarter and the next is 56.2% and 13.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.81%.
Volatility
Advanced Energy Industries's last day, last week, and last month's current intraday variation average was 6.06%, 2.50%, and 1.95%, respectively.
Advanced Energy Industries's highest amplitude of average volatility was 6.85% (day), 2.98% (last week), and 3.21% (last month), respectively.
Advanced Energy Industries's Stock Yearly Top and Bottom Value
Advanced Energy Industries's stock is valued at $90.63 at 11:25 EST, under its 52-week high of $98.07 and way above its 52-week low of $67.55.
Advanced Energy Industries's Moving Average
Advanced Energy Industries's value is above its 50-day moving average of $83.70 and above its 200-day moving average of $84.17.5. West Pharmaceutical (WST)
5.8% sales growth and 30.76% return on equity
West Pharmaceutical Services, Inc. manufactures, sells, and designs containment and delivery system for injectable medicines and other healthcare products. It is located in Americas, Europe, Middle East, Africa, Asia Pacific, Middle East, Africa, Asia Pacific, and Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. It offers stoppers for injectable packaging systems, syringe components and contract-manufactured products. Crystal Zenith is a cyclic-olefin-polymer that can be used to make drug containment products. It comes in vials and syringes as cartridges and self-injection device. The segment is available to pharmaceutical, generic and biologic drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This company serves medical, diagnostic and pharmaceutical companies. It distributes products via its distribution network and sales team, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc., was founded in 1923. It is located in Exton, Pennsylvania.
West Pharmaceutical's sales growth this year is expected to be 6.4% and 6.7% for next year.
Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 2.93B for the twelve trailing months.
Volume
Today's last reported volume for West Pharmaceutical is 288889 which is 23.21% below its average volume of 376237.
West Pharmaceutical's sales growth for the next quarter is 5.8%. The company's growth estimates for the ongoing quarter and the next is 12.1% and 22.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.76%.
Volatility
West Pharmaceutical's last day, last week, and last month's current intraday variation average was 0.74%, 3.06%, and 1.67%, respectively.
West Pharmaceutical's highest amplitude of average volatility was 2.79% (day), 3.26% (last week), and 2.86% (last month), respectively.
West Pharmaceutical's Stock Yearly Top and Bottom Value
West Pharmaceutical's stock is valued at $279.82 at 11:27 EST, way under its 52-week high of $475.00 and above its 52-week low of $275.89.
West Pharmaceutical's Moving Average
West Pharmaceutical's worth is way below its 50-day moving average of $316.26 and way below its 200-day moving average of $359.75.6. Manhattan Associates (MANH)
5.7% sales growth and 56.34% return on equity
Manhattan Associates, Inc. designs, develops, deploys, supports, and maintains software solutions that manage inventory, supply chain, and omnichannel operations. This includes products for wholesalers, retailers, manufacturers, logistic providers, and others. Manhattan SCALE is a suite of logistics execution tools that provides trading partner management and optimization as well as warehouse and transport execution services. Manhattan Active offers a range of enterprise- and store-specific omnichannel solutions. The company also offers inventory optimization and planning services. It provides maintenance services that include customer support and software enhancements. Professional services such as solution planning and implementation and associated consulting services. Training and management services are available. The company also resells radio frequency terminal networks and radio frequency identification chips readers as well as computer hardware and peripherals. The company offers its products via direct sales staff as well as partnership agreements with different organizations. It operates across the Americas and Europe as well as in Africa, Asia Pacific, Europe, Middle East, Africa, Middle East, Africa, Asia, and Africa. Manhattan Associates, Inc. was established in 1990. It is located in Atlanta, Georgia.
Manhattan Associates's sales growth this year is expected to be 11.2% and 10.9% for next year.
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 711.56M for the twelve trailing months.
Volume
Today's last reported volume for Manhattan Associates is 135668 which is 56.7% below its average volume of 313326.
Manhattan Associates's sales growth for the next quarter is 5.7%. The company's growth estimates for the present quarter and the next is a negative 19.7% and 2.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 56.34%.
Volatility
Manhattan Associates's last day, last week, and last month's current intraday variation average was 0.12%, 1.54%, and 1.44%, respectively.
Manhattan Associates's highest amplitude of average volatility was 1.50% (day), 2.23% (last week), and 2.20% (last month), respectively.
Manhattan Associates's Stock Yearly Top and Bottom Value
Manhattan Associates's stock is valued at $138.62 at 11:28 EST, way below its 52-week high of $188.52 and way higher than its 52-week low of $106.02.